DK164455C - 1h-imidazooe4,5-caaquinolin-4-chlorforbindelser - Google Patents

1h-imidazooe4,5-caaquinolin-4-chlorforbindelser

Info

Publication number: DK164455C
Authority: DK; Denmark
Prior art keywords: carbon atoms; compounds; group; imidazooe4; caaquinolin
Prior art date: 1983-11-18

Application number

DK135891A

Other languages

English (en)

Other versions

DK135891D0 (da

DK164455B (da

DK135891A (da

Inventor

John F Gerster

Original Assignee

Riker Laboratories Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1983-11-18

Filing date

1991-07-16

Publication date

1992-11-16

1991-07-16 Application filed by Riker Laboratories Inc filed Critical Riker Laboratories Inc

1991-07-16 Publication of DK135891D0 publication Critical patent/DK135891D0/da

1991-07-16 Publication of DK135891A publication Critical patent/DK135891A/da

1992-06-29 Publication of DK164455B publication Critical patent/DK164455B/da

1992-11-16 Application granted granted Critical

1992-11-16 Publication of DK164455C publication Critical patent/DK164455C/da

Links

125000004432 carbon atom Chemical group C* 0.000 abstract 5
125000000217 alkyl group Chemical group 0.000 abstract 2
150000001875 compounds Chemical class 0.000 abstract 2
ITIRVXDSMXFTPW-UHFFFAOYSA-N 1H-imidazo[4,5-c]quinoline Chemical class C1=CC=CC2=C(NC=N3)C3=CN=C21 ITIRVXDSMXFTPW-UHFFFAOYSA-N 0.000 abstract 1
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
125000003545 alkoxy group Chemical group 0.000 abstract 1
230000015572 biosynthetic process Effects 0.000 abstract 1
125000004210 cyclohexylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 abstract 1
229910052736 halogen Inorganic materials 0.000 abstract 1
150000002367 halogens Chemical class 0.000 abstract 1
229910052739 hydrogen Inorganic materials 0.000 abstract 1
239000001257 hydrogen Substances 0.000 abstract 1
125000002768 hydroxyalkyl group Chemical group 0.000 abstract 1
239000000543 intermediate Substances 0.000 abstract 1
125000001424 substituent group Chemical group 0.000 abstract 1
238000003786 synthesis reaction Methods 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
- C07D215/42—Nitrogen atoms attached in position 4

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Communicable Diseases (AREA)
Virology (AREA)
Bioinformatics & Cheminformatics (AREA)
Pulmonology (AREA)
Oncology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Plural Heterocyclic Compounds (AREA)
Physical Water Treatments (AREA)
Macromonomer-Based Addition Polymer (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Quinoline Compounds (AREA)
Alarm Systems (AREA)
Lubricants (AREA)
Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
Luminescent Compositions (AREA)

DK135891A 1983-11-18 1991-07-16 1h-imidazooe4,5-caaquinolin-4-chlorforbindelser DK164455C (da)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date
US55315883A	1983-11-18	1983-11-18
US55315783A	1983-11-18	1983-11-18
US55315783		1983-11-18
US55315883		1983-11-18

Publications (4)

Publication Number	Publication Date
DK135891D0 DK135891D0 (da)	1991-07-16
DK135891A DK135891A (da)	1991-07-16
DK164455B DK164455B (da)	1992-06-29
DK164455C true DK164455C (da)	1992-11-16

Family

ID=27070262

Family Applications (6)

Application Number	Title	Priority Date	Filing Date
DK542684A DK164280C (da)	1983-11-18	1984-11-15	1h-imidazooe4,5-caaquinolin eller derivat deraf og farmaceutisk praeparat indeholdende en saadan forbindelse
DK135891A DK164455C (da)	1983-11-18	1991-07-16	1h-imidazooe4,5-caaquinolin-4-chlorforbindelser
DK135791A DK169179B1 (da)	1983-11-18	1991-07-16	1H-imidazo[4,5-c]quinolin-4-amin, farmaceutisk præparat indeholdende en sådan forbindelse og fremga ngsmåde til fremstilling af en sådan forbindelse
DK136091A DK164451C (da)	1983-11-18	1991-07-16	3-aminoquinolinderivat
DK135991A DK165921C (da)	1983-11-18	1991-07-16	1h-imidazooe4,5-caaquinolin-5-oxyforbindelser
DK136191A DK164452C (da)	1983-11-18	1991-07-16	3-nitroquinolinderivat

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
DK542684A DK164280C (da)	1983-11-18	1984-11-15	1h-imidazooe4,5-caaquinolin eller derivat deraf og farmaceutisk praeparat indeholdende en saadan forbindelse

Family Applications After (4)

Application Number	Title	Priority Date	Filing Date
DK135791A DK169179B1 (da)	1983-11-18	1991-07-16	1H-imidazo[4,5-c]quinolin-4-amin, farmaceutisk præparat indeholdende en sådan forbindelse og fremga ngsmåde til fremstilling af en sådan forbindelse
DK136091A DK164451C (da)	1983-11-18	1991-07-16	3-aminoquinolinderivat
DK135991A DK165921C (da)	1983-11-18	1991-07-16	1h-imidazooe4,5-caaquinolin-5-oxyforbindelser
DK136191A DK164452C (da)	1983-11-18	1991-07-16	3-nitroquinolinderivat

Country Status (15)

Country	Link
EP (2)	EP0310950B1 (da)
JP (1)	JPS60123488A (da)
KR (1)	KR900005657B1 (da)
AT (2)	ATE84525T1 (da)
AU (2)	AU581190B2 (da)
CA (1)	CA1271477A (da)
DE (3)	DE3486043T2 (da)
DK (6)	DK164280C (da)
ES (1)	ES8603477A1 (da)
IE (1)	IE57874B1 (da)
IL (2)	IL84537A (da)
NL (2)	NL980043I1 (da)
NO (7)	NO163819C (da)
NZ (1)	NZ210228A (da)
PH (1)	PH22338A (da)

Families Citing this family (74)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA1306260C (en) *	1985-10-18	1992-08-11	Shionogi & Co., Ltd.	Condensed imidazopyridine derivatives
US4942168A (en) *	1987-07-13	1990-07-17	Hoechst-Roussel Pharmaceuticals Inc.	Hydroxyquinoline amines, and method of enhancing memory in mammals
CA1335996C (en) *	1988-02-16	1995-06-20	Susumu Takada	2-substituted carbonylimidazo¬4,5-c\|quinolines
EP0361489A3 (en) *	1988-09-30	1991-06-12	Chugai Seiyaku Kabushiki Kaisha	Novel 3,4-diaminoquinoline and pyridine compounds
DK0385630T3 (da) *	1989-02-27	1997-05-12	Riker Laboratories Inc	1H-imidazo(4,5-c)quinolin-4-aminer som antivirale midler
CA2011504C (en) *	1989-03-07	1998-06-02	Kenji Ohmori	Imidazoquinolone derivatives
US4929624A (en) *	1989-03-23	1990-05-29	Minnesota Mining And Manufacturing Company	Olefinic 1H-imidazo(4,5-c)quinolin-4-amines
CA2021338C (en) *	1989-07-18	1996-07-16	Fumio Suzuki	Imidazoquinolone derivatives
US4988815A (en) *	1989-10-26	1991-01-29	Riker Laboratories, Inc.	3-Amino or 3-nitro quinoline compounds which are intermediates in preparing 1H-imidazo[4,5-c]quinolines
FR2654021B1 (fr) *	1989-11-07	1992-02-28	Simond Jacques	Procede de vitrification de cendres volantes et dispositif pour sa mise en óoeuvre.
GB8928281D0 (en) *	1989-12-14	1990-02-21	Smith Kline French Lab	Compounds
CA2043715C (en) *	1990-06-01	1997-01-07	Fumio Suzuki	Imidazonaphthyridine derivatives
UA32546C2 (uk) *	1991-03-01	2001-02-15	Міннесота Майнінг Енд Мен'Юфекчурінг Компані	1,2-заміщені 1н-імідазо[4,5-с]хінолін-4-аміни, проміжні сполуки для їх синтезу, антивірусна фармацевтична композиція, спосіб лікування інфікованих ссавців, спосіб індукування біосинтезу інтерферону у ссавців, спосіб уповільнення росту бластом
US5266575A (en) *	1991-11-06	1993-11-30	Minnesota Mining And Manufacturing Company	2-ethyl 1H-imidazo[4,5-ciquinolin-4-amines
IL105325A (en) *	1992-04-16	1996-11-14	Minnesota Mining & Mfg	Immunogen/vaccine adjuvant composition
US5395937A (en) *	1993-01-29	1995-03-07	Minnesota Mining And Manufacturing Company	Process for preparing quinoline amines
US5693811A (en) *	1996-06-21	1997-12-02	Minnesota Mining And Manufacturing Company	Process for preparing tetrahdroimidazoquinolinamines
WO1998030562A1 (en) *	1997-01-09	1998-07-16	Terumo Kabushiki Kaisha	Novel amide derivatives and intermediates for the synthesis thereof
JPH10298181A (ja) *	1997-04-25	1998-11-10	Sumitomo Pharmaceut Co Ltd	タイプ２ヘルパーｔ細胞選択的免疫応答抑制剤
JP2000119271A (ja) *	1998-08-12	2000-04-25	Hokuriku Seiyaku Co Ltd	１ｈ―イミダゾピリジン誘導体
UA74852C2 (en) *	2000-12-08	2006-02-15	3M Innovative Properties Co	Urea-substituted imidazoquinoline ethers
EP2332922A1 (en) *	2001-10-23	2011-06-15	Merck Serono S.A.	N-substituted azoles and their use as MEK-1 and/or ERK-2 modulators
GB0211649D0 (en)	2002-05-21	2002-07-03	Novartis Ag	Organic compounds
KR20050028047A (ko)	2002-07-23	2005-03-21	비오갈 기오기스제르갸르 알티.	1ｈ-이미다조[4,5-ｃ]퀴놀린-4-프탈이미드 중간체를 통한1ｈ-이미다조[4,5-ｃ]퀴놀린-4-아민의 제조
ATE357445T1 (de)	2002-07-26	2007-04-15	Teva Gyogyszergyar Zartkoeruee	Darstellung von 1h-imidazo(4,5-c)chinolin-4- aminen über neue 1h-imidazo(4,5-c)chinolin-4- cyano- und 1h-imidazo(4,5-c)chinolin-4-carboxamid intermediate
AR045260A1 (es)	2003-08-12	2005-10-19	3M Innovative Properties Co	Compuestos que contienen imidazo-oxima sustituidos
AU2004268625B2 (en) *	2003-08-27	2011-03-31	3M Innovative Properties Company	Aryloxy and arylalkyleneoxy substituted imidazoquinolines
CA2537763A1 (en)	2003-09-05	2005-03-17	3M Innovative Properties Company	Treatment for cd5+ b cell lymphoma
CA2536530A1 (en)	2003-10-01	2005-04-14	Taro Pharmaceuticals U.S.A., Inc.	Method of preparing 4-amino-1h-imidazo(4,5-c)quinolines and acid addition salts thereof
EP1673087B1 (en)	2003-10-03	2015-05-13	3M Innovative Properties Company	Alkoxy substituted imidazoquinolines
US7544697B2 (en)	2003-10-03	2009-06-09	Coley Pharmaceutical Group, Inc.	Pyrazolopyridines and analogs thereof
ITMI20032121A1 (it) *	2003-11-04	2005-05-05	Dinamite Dipharma Spa In Forma Abbr Eviata Dipharm	Procedimento per la preparazione di imiquimod e suoi intermedi
CA2545774A1 (en)	2003-11-14	2005-06-02	3M Innovative Properties Company	Oxime substituted imidazo ring compounds
JP2007511535A (ja)	2003-11-14	2007-05-10	スリーエムイノベイティブプロパティズカンパニー	ヒドロキシルアミン置換イミダゾ環化合物
EP1687307B1 (en)	2003-11-25	2016-01-06	3M Innovative Properties Company	Substituted imidazo ring systems and methods
WO2005066170A1 (en)	2003-12-29	2005-07-21	3M Innovative Properties Company	Arylalkenyl and arylalkynyl substituted imidazoquinolines
CA2551399A1 (en)	2003-12-30	2005-07-21	3M Innovative Properties Company	Imidazoquinolinyl, imidazopyridinyl, and imidazonaphthyridinyl sulfonamides
US8697873B2 (en)	2004-03-24	2014-04-15	3M Innovative Properties Company	Amide substituted imidazopyridines, imidazoquinolines, and imidazonaphthyridines
WO2005123080A2 (en)	2004-06-15	2005-12-29	3M Innovative Properties Company	Nitrogen-containing heterocyclyl substituted imidazoquinolines and imidazonaphthyridines
US7897609B2 (en)	2004-06-18	2011-03-01	3M Innovative Properties Company	Aryl substituted imidazonaphthyridines
WO2006009826A1 (en)	2004-06-18	2006-01-26	3M Innovative Properties Company	Aryloxy and arylalkyleneoxy substituted thiazoloquinolines and thiazolonaphthyridines
US7915281B2 (en)	2004-06-18	2011-03-29	3M Innovative Properties Company	Isoxazole, dihydroisoxazole, and oxadiazole substituted imidazo ring compounds and method
AU2005326708C1 (en)	2004-12-30	2012-08-30	3M Innovative Properties Company	Substituted chiral fused [1,2]imidazo[4,5-c] ring compounds
EP1831226B1 (en)	2004-12-30	2012-08-08	3M Innovative Properties Company	Chiral tetracyclic compounds inducing interferon biosynthesis
WO2006084251A2 (en)	2005-02-04	2006-08-10	Coley Pharmaceutical Group, Inc.	Aqueous gel formulations containing immune reponse modifiers
WO2006086634A2 (en)	2005-02-11	2006-08-17	Coley Pharmaceutical Group, Inc.	Oxime and hydroxylamine substituted imidazo[4,5-c] ring compounds and methods
US7943610B2 (en)	2005-04-01	2011-05-17	3M Innovative Properties Company	Pyrazolopyridine-1,4-diamines and analogs thereof
EP1863814A1 (en)	2005-04-01	2007-12-12	Coley Pharmaceutical Group, Inc.	1-substituted pyrazolo (3,4-c) ring compounds as modulators of cytokine biosynthesis for the treatment of viral infections and neoplastic diseases
ES2577514T3 (es)	2005-08-22	2016-07-15	The Regents Of The University Of California	Antagonistas de TLR
US8846697B2 (en)	2006-05-31	2014-09-30	The Regents Of The University Of California	Purine analogs
US7906506B2 (en)	2006-07-12	2011-03-15	3M Innovative Properties Company	Substituted chiral fused [1,2] imidazo [4,5-c] ring compounds and methods
DK2510946T3 (da)	2007-02-07	2015-11-02	Univ California	Konjugater af syntetiske tlr-agonister og anvendelser deraf
EP2009002A1 (en) *	2007-06-21	2008-12-31	Institut National De La Sante Et De La Recherche Medicale (Inserm)	New process for the manufacture of 1H-imidazo [4,5-c]-quinoline ring systems
WO2010088924A1 (en)	2009-02-06	2010-08-12	Telormedix Sa	Pharmaceutical compositions comprising imidazoquinolin(amines) and derivatives thereof suitable for local administration
EP2396328A2 (en)	2009-02-11	2011-12-21	The Regents of The University of California	Toll-like receptor modulators and treatment of diseases
CA2808624C (en)	2010-08-17	2019-05-14	3M Innovative Properties Company	Lipidated immune response modifier compound compositions, formulations, and methods
US8728486B2 (en)	2011-05-18	2014-05-20	University Of Kansas	Toll-like receptor-7 and -8 modulatory 1H imidazoquinoline derived compounds
IN2014KN00948A (da)	2011-10-04	2015-08-21	Janus Biotherapeutics Inc
CA3102531A1 (en) *	2013-02-01	2014-08-07	Wellstat Therapeutics Corporation	Substituted quinazolin-4-amine compounds and pharmaceutical compositions thereof having anti-inflammatory, antifungal, antiparasitic and anticancer activity
CN105189495A (zh) *	2013-03-15	2015-12-23	先正达参股股份有限公司	新颖的杀微生物剂
ES2538880B1 (es) *	2013-12-24	2016-09-08	Laboratorios Viñas S.A.	Un procedimiento para obtener 4-amino-1-isobutil-1H-imidazo[4,5-c]quinoleína
JP2017503803A (ja)	2014-01-10	2017-02-02	シャンハイバーディーバイオテックインコーポレイテッド	Ｅｇｆｒ発現腫瘍を処置するための化合物及び組成物
EP3166976B1 (en)	2014-07-09	2022-02-23	Birdie Biopharmaceuticals Inc.	Anti-pd-l1 combinations for treating tumors
MX377305B (es) *	2015-09-14	2025-03-07	Pfizer	DERIVADOS DE IMIDAZO[4,5-c]QUINOLINA E IMIDAZO[4,5-c][1,5]NAFTIRIDINA NOVEDOSOS COMO INHIBIDORES DE LRRK2.
CN106943596A (zh)	2016-01-07	2017-07-14	博笛生物科技（北京）有限公司	用于治疗肿瘤的抗-cd20组合
CN106943597A (zh)	2016-01-07	2017-07-14	博笛生物科技（北京）有限公司	用于治疗肿瘤的抗-egfr组合
WO2017184735A1 (en) *	2016-04-19	2017-10-26	Ifm Therapeutics, Inc	Nlrp3 modulators
KR20180134395A (ko)	2016-04-19	2018-12-18	인네이트 튜머 이뮤니티, 인코포레이티드	Nlrp3 조정제
US11697851B2 (en)	2016-05-24	2023-07-11	The Regents Of The University Of California	Early ovarian cancer detection diagnostic test based on mRNA isoforms
TWI674261B (zh)	2017-02-17	2019-10-11	美商英能腫瘤免疫股份有限公司	Nlrp3 調節劑
CN108794467A (zh)	2017-04-27	2018-11-13	博笛生物科技有限公司	2-氨基-喹啉衍生物
CA3067268A1 (en)	2017-06-23	2018-12-27	Birdie Biopharmaceuticals, Inc.	Crystalline resiquimod monosulfate anhydrate and its preparation and uses
FR3113287B1 (fr)	2020-08-07	2023-06-23	Phv Pharma	Procédé industriel de synthèse de l’imiquimod à partir de la quinolèine-2,4-diol applicable à son utilisation pharmaceutique
KR20230118101A (ko) *	2020-12-09	2023-08-10	웰스태트 테러퓨틱스 코포레이션	항염증, 항진균, 항기생충 및 항암 활성을 갖는 이미다조퀴놀린 화합물

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3700674A (en) *	1969-04-30	1972-10-24	American Cyanamid Co	4-alkylamino-3-nitroquinolines
RO86850B (ro) *	1982-05-03	1985-05-31	Eli Lilly And Company	Procedeu pentru prepararea unor 2-fenilimidazo [4,5 c] piridine

1984
- 1984-11-13 CA CA000467706A patent/CA1271477A/en not_active Expired - Lifetime
- 1984-11-14 AU AU35402/84A patent/AU581190B2/en not_active Expired
- 1984-11-15 DK DK542684A patent/DK164280C/da not_active IP Right Cessation
- 1984-11-15 NO NO844565A patent/NO163819C/no not_active IP Right Cessation
- 1984-11-15 ES ES537677A patent/ES8603477A1/es not_active Expired
- 1984-11-16 EP EP88116137A patent/EP0310950B1/en not_active Expired - Lifetime
- 1984-11-16 PH PH31451A patent/PH22338A/en unknown
- 1984-11-16 AT AT88116137T patent/ATE84525T1/de not_active IP Right Cessation
- 1984-11-16 IE IE2952/84A patent/IE57874B1/en not_active IP Right Cessation
- 1984-11-16 IL IL84537A patent/IL84537A/xx not_active IP Right Cessation
- 1984-11-16 DE DE8888116137T patent/DE3486043T2/de not_active Expired - Lifetime
- 1984-11-16 EP EP84307974A patent/EP0145340B1/en not_active Expired - Lifetime
- 1984-11-16 AT AT84307974T patent/ATE49763T1/de active
- 1984-11-16 NZ NZ210228A patent/NZ210228A/xx unknown
- 1984-11-16 DE DE8484307974T patent/DE3481124D1/de not_active Expired - Lifetime
- 1984-11-16 DE DE1999175027 patent/DE19975027I2/de active Active
- 1984-11-17 KR KR1019840007224A patent/KR900005657B1/ko not_active Expired
- 1984-11-17 JP JP59243142A patent/JPS60123488A/ja active Granted
1987
- 1987-11-19 IL IL84537A patent/IL84537A0/xx unknown
1989
- 1989-02-14 AU AU29911/89A patent/AU611997B2/en not_active Expired
- 1989-02-27 NO NO890823A patent/NO165146C/no not_active IP Right Cessation
- 1989-02-27 NO NO890824A patent/NO165147C/no not_active IP Right Cessation
- 1989-02-27 NO NO890826A patent/NO168705C/no not_active IP Right Cessation
- 1989-02-27 NO NO890822A patent/NO165145C/no not_active IP Right Cessation
- 1989-02-27 NO NO890825A patent/NO169437C/no not_active IP Right Cessation
1991
- 1991-07-16 DK DK135891A patent/DK164455C/da not_active IP Right Cessation
- 1991-07-16 DK DK135791A patent/DK169179B1/da not_active IP Right Cessation
- 1991-07-16 DK DK136091A patent/DK164451C/da not_active IP Right Cessation
- 1991-07-16 DK DK135991A patent/DK165921C/da not_active IP Right Cessation
- 1991-07-16 DK DK136191A patent/DK164452C/da not_active IP Right Cessation
1998
- 1998-12-14 NL NL980043C patent/NL980043I1/nl unknown
- 1998-12-14 NL NL980041C patent/NL980041I2/nl unknown
1999
- 1999-07-08 NO NO1999015C patent/NO1999015I1/no unknown

Also Published As

Publication number	Publication date
DK164280B (da)	1992-06-01
IL84537A (en)	1990-12-23
KR900005657B1 (ko)	1990-08-03
NO890823D0 (no)	1989-02-27
DK164280C (da)	1992-11-30
EP0145340A3 (en)	1986-06-11
NO890822D0 (no)	1989-02-27
NO890824D0 (no)	1989-02-27
ATE84525T1 (de)	1993-01-15
DK136091D0 (da)	1991-07-16
DK136091A (da)	1991-07-16
DK165921B (da)	1993-02-08
DK135891D0 (da)	1991-07-16
EP0145340A2 (en)	1985-06-19
DK165921C (da)	1993-06-28
DK136191A (da)	1991-07-16
ES537677A0 (es)	1985-12-16
DK136191D0 (da)	1991-07-16
AU611997B2 (en)	1991-06-27
NO890824L (no)	1985-05-20
ATE49763T1 (de)	1990-02-15
PH22338A (en)	1988-08-12
IE842952L (en)	1985-05-18
DK135991D0 (da)	1991-07-16
NO890826L (no)	1985-05-20
EP0145340B1 (en)	1990-01-24
IE57874B1 (en)	1993-05-05
NO169437B (no)	1992-03-16
DK542684A (da)	1985-05-19
DE3481124D1 (de)	1990-03-01
DK542684D0 (da)	1984-11-15
DK164451C (da)	1992-11-09
EP0310950A1 (en)	1989-04-12
DK169179B1 (da)	1994-09-05
EP0310950B1 (en)	1993-01-13
NL980041I1 (nl)	1999-02-01
NO165146B (no)	1990-09-24
DE3486043D1 (de)	1993-02-25
NO890825L (no)	1985-05-20
NO890822L (no)	1985-05-20
AU581190B2 (en)	1989-02-16
DK164455B (da)	1992-06-29
DK135791D0 (da)	1991-07-16
NL980041I2 (nl)	1999-07-01
NO844565L (no)	1985-05-20
NO168705B (no)	1991-12-16
DE19975027I2 (de)	2000-09-21
DK164452B (da)	1992-06-29
ES8603477A1 (es)	1985-12-16
JPS60123488A (ja)	1985-07-02
IL84537A0 (en)	1988-04-29
NO165147C (no)	1991-01-02
DK164451B (da)	1992-06-29
NO1999015I1 (no)	1999-07-08
NO163819B (no)	1990-04-17
AU3540284A (en)	1985-05-23
NO165147B (no)	1990-09-24
NO890823L (no)	1985-05-20
DE3486043T2 (de)	1993-06-03
NO890825D0 (no)	1989-02-27
NO163819C (no)	1990-08-01
NO168705C (no)	1992-03-25
NL980043I1 (nl)	1999-02-01
NO890826D0 (no)	1989-02-27
DK135791A (da)	1991-07-16
DK135891A (da)	1991-07-16
NZ210228A (en)	1989-01-27
JPH0586391B2 (da)	1993-12-10
DK135991A (da)	1991-07-16
AU2991189A (en)	1989-06-15
DK164452C (da)	1992-11-09
NO165145C (no)	1991-01-02
NO165146C (no)	1991-01-02
NO165145B (no)	1990-09-24
NO169437C (no)	1992-06-24
CA1271477A (en)	1990-07-10
KR850003890A (ko)	1985-06-29

Legal Events

Date	Code	Title	Description
2004-12-06	PUP	Patent expired